Bilal Ahmed Siddiqui, Benedito A. Carneiro, Mark N. Stein, Jingsong Zhang, William Kevin Kelly, David R Wise, Kai Tsao, Gerald Steven Falchook, Przemyslaw Twardowski, Xin Gao, Joseph W. Kim, Edward Paul Gelmann, Pradeep Thanigaimani, Fang Fang, Frank A. Seebach, Israel Lowy, Matthew Ingham, Michael David Kinnaman, Sabina Sandigursky, Elizabeth Miller. "A phase 1/2 study of nezastomig (anti-PSMA×CD28) with or without cemiplimab (anti–PD-1) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and clear cell renal cell carcinoma (ccRCC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.tps293